Docetaxel-induced Stevens-Johnson syndrome with regenerating epidermis composed of atypical keratinocytes.
Sawada
Y
Y
Sugita
K
K
Kabashima
R
R
Nakamura
M
M
Tokura
Y
Y
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D000077143:Docetaxel; D004817:Epidermis / Q000473:pathology*; D005260:Female; D006801:Humans; D015603:Keratinocytes / Q000473:pathology*; D008875:Middle Aged; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D043823:Taxoids / Q000009:adverse effects* / Q000627:therapeutic use
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel